Who Paid My Doc
Mark Dalton
Foot and Ankle Surgery Austin, TX Medical Doctor
NPI 1457324816 CMS profile 111516
4700 Seton Center Pkwy Ste 200, Austin, TX 78759
General payments
$1,922,834
Research payments
$0
Ownership & investment interest
$11,421,329
Through program year 2025, Mark Dalton of Austin, TX is reported in the CMS Open Payments database as having received $1,922,834 across 615 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $11,421,329 across 7 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
14 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $74,988 | 39 | |
| 2024 | General | $183,091 | 65 | |
| 2023 | General | $347,146 | 115 | |
| 2022 | General | $401,016 | 96 | |
| 2021 | General | $491,369 | 115 | |
| 2020 | General | $157,739 | 99 | |
| 2019 | General | $267,486 | 86 | |
| 2025 | Ownership | $2,194,472 | 1 | |
| 2024 | Ownership | $2,194,472 | 1 | |
| 2023 | Ownership | $2,194,472 | 1 | |
| 2022 | Ownership | $1,394,469 | 1 | |
| 2021 | Ownership | $1,169,479 | 1 | |
| 2020 | Ownership | $1,144,480 | 1 | |
| 2019 | Ownership | $1,129,485 | 1 |
Beside peers
- Mark Dalton
- Foot and Ankle Surgery median
- Middle half of Foot and Ankle Surgery
- National median
In program year 2025, general payments to Mark Dalton were reported at $74,988. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.
Show as a table
| Year | Mark Dalton | Foot and Ankle Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $267,486 | $1,327 | $279–$5,421 | $163 |
| 2020 | $157,739 | $795 | $121–$3,473 | $114 |
| 2021 | $491,369 | $1,289 | $201–$4,963 | $132 |
| 2022 | $401,016 | $1,539 | $270–$6,067 | $149 |
| 2023 | $347,146 | $1,117 | $257–$5,264 | $160 |
| 2024 | $183,091 | $1,064 | $235–$4,944 | $164 |
| 2025 | $74,988 | $1,183 | $267–$6,309 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
615 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Foot and Ankle Surgery in Texas
William McGarvey
Foot and Ankle Surgery · Katy, TX
Eugene Curry
Foot and Ankle Surgery · Dallas, TX
Kevin Varner
Foot and Ankle Surgery · Houston, TX
John Early
Foot and Ankle Surgery · Dallas, TX
Vinod Panchbhavi
Foot and Ankle Surgery · Galveston, TX
Taggart Gauvain
Foot and Ankle Surgery · Pearland, TX
Related records
Foot and Ankle Surgery in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Foot and Ankle Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.